CytomX Therapeutics, Inc.
Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereof

Abstract:

The invention relates generally to antibodies that bind CD71, activatable antibodies that specifically bind to CD71 and methods of making and using these anti-CD71 antibodies and anti-CD71 activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.